These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32140075)

  • 1. ROBO4 deletion ameliorates PAF-mediated skin inflammation via regulating the mRNA translation efficiency of LPCAT1/LPCAT2 and the expression of PAF receptor.
    Xiao X; Zhuang X; Xu C; Chen H; Zhu W; Pang C; Zhang M
    Int J Biol Sci; 2020; 16(6):1086-1095. PubMed ID: 32140075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of platelet-activating factor synthases and its receptor in spinal cord contribute to development of neuropathic pain following peripheral nerve injury.
    Okubo M; Yamanaka H; Kobayashi K; Kanda H; Dai Y; Noguchi K
    Mol Pain; 2012 Feb; 8():8. PubMed ID: 22296727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of LPCAT expression increases platelet-activating factor level in cirrhotic rat liver: potential antiinflammatory effect of silybin.
    Stanca E; Serviddio G; Bellanti F; Vendemiale G; Siculella L; Giudetti AM
    Biochim Biophys Acta; 2013 Dec; 1832(12):2019-26. PubMed ID: 23851051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
    Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop.
    Shindou H; Shiraishi S; Tokuoka SM; Takahashi Y; Harayama T; Abe T; Bando K; Miyano K; Kita Y; Uezono Y; Shimizu T
    FASEB J; 2017 Jul; 31(7):2973-2980. PubMed ID: 28341636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid production of platelet-activating factor is induced by protein kinase Cα-mediated phosphorylation of lysophosphatidylcholine acyltransferase 2 protein.
    Morimoto R; Shindou H; Tarui M; Shimizu T
    J Biol Chem; 2014 May; 289(22):15566-76. PubMed ID: 24742674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor.
    Harayama T; Shindou H; Ogasawara R; Suwabe A; Shimizu T
    J Biol Chem; 2008 Apr; 283(17):11097-106. PubMed ID: 18285344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibitors of a PAF biosynthetic enzyme lysophosphatidylcholine acyltransferase 2.
    Tarui M; Shindou H; Kumagai K; Morimoto R; Harayama T; Hashidate T; Kojima H; Okabe T; Nagano T; Nagase T; Shimizu T
    J Lipid Res; 2014 Jul; 55(7):1386-96. PubMed ID: 24850807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.
    Cheng L; Han X; Shi Y
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1276-82. PubMed ID: 19773578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation.
    Yamaguchi M; Matsui M; Higa R; Yamazaki Y; Ikari A; Miyake M; Miwa M; Ishii S; Sugatani J; Shimizu T
    Biochem Pharmacol; 2015 Feb; 93(4):482-95. PubMed ID: 25577975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of lysophosphatidylcholine acyltransferase 2 at Ser34 enhances platelet-activating factor production in endotoxin-stimulated macrophages.
    Morimoto R; Shindou H; Oda Y; Shimizu T
    J Biol Chem; 2010 Sep; 285(39):29857-62. PubMed ID: 20663880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL: relevance to the inflammatory phase of atherogenesis.
    Stengel D; Antonucci M; Arborati M; Hourton D; Griglio S; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):954-62. PubMed ID: 9157961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
    Han C; Yu G; Mao Y; Song S; Li L; Zhou L; Wang Z; Liu Y; Li M; Xu B
    PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways.
    Howard KM; Abdel-Al M; Ditmyer M; Patel N
    Inflamm Res; 2011 Aug; 60(8):735-44. PubMed ID: 21432021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAFR activation of NF-κB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages.
    Ishizuka EK; Filgueiras LR; Rios FJ; Serezani CH; Jancar S
    Sci Rep; 2016 Aug; 6():32092. PubMed ID: 27554194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects.
    Verouti SN; Fragopoulou E; Karantonis HC; Dimitriou AA; Tselepis AD; Antonopoulou S; Nomikos T; Demopoulos CA
    Atherosclerosis; 2011 Dec; 219(2):519-25. PubMed ID: 21920519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.
    Chaithra VH; Jacob SP; Lakshmikanth CL; Sumanth MS; Abhilasha KV; Chen CH; Thyagarajan A; Sahu RP; Travers JB; McIntyre TM; Kemparaju K; Marathe GK
    J Lipid Res; 2018 Nov; 59(11):2063-2074. PubMed ID: 30139761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021.
    Xia SH; Hu CX; Zhao ZL; Xia GD; Di Y
    World J Gastroenterol; 2007 Jun; 13(21):2992-8. PubMed ID: 17589953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.
    Tian Z; Chu T; Shields LBE; Zhu Q; Zhang YP; Kong M; Barnes GN; Wang Y; Shields CB; Cai J
    Mol Neurobiol; 2020 Oct; 57(10):4069-4081. PubMed ID: 32661728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis and homology modeling reveal a predicted pocket of lysophosphatidylcholine acyltransferase 2 to catch Acyl-CoA.
    Hamano F; Matoba K; Hashidate-Yoshida T; Suzuki T; Miura K; Hishikawa D; Harayama T; Yuki K; Kita Y; Noda NN; Shimizu T; Shindou H
    FASEB J; 2021 Jun; 35(6):e21501. PubMed ID: 33956375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.